Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Scientific Reports|April 15, 2025
Biomarker and cognitive decline in atrial fibrillation: a prospective cohort studyPhilipp Krisai, Magdalena Eberl, Michael Coslovsky, et al.
Journal of the American Heart Association|November 10, 2021
Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss-AF StudyArjola Bano, Nicolas Rodondi, Jürg H Beer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2023
Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial ApproachMiquel Serra-Burriel, Helena Aebersold, Fabienne Foster-Witassek, et al.
Plos One|October 9, 2020
A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)Anne Springer, Andreas U Monsch, Gilles Dutilh, et al.
Journal of the American Heart Association|June 1, 2023
Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial FibrillationPhilipp Baumgartner, Martin F Reiner, Andrea Wiencierz, et al.
Thrombosis Research|December 16, 2018
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolismMartin F Reiner, Daniel Müller, Sara Gobbato, et al.
International Journal of Cardiology|April 7, 2018
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injuryCandela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|September 15, 2020
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic systemLuca Liberale, Alexander Akhmedov, Nikolaos I Vlachogiannis, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonistsM Nagler, A Angelillo-Scherrer, M Méan, et al.
Stroke|September 17, 2025
Plasma β-Thromboglobulin Is Inversely Associated With Cerebral Microbleeds in Atrial FibrillationBenedict C Kupper, Martin F Reiner, Laura Werlen, et al.
Pageof 23